• logo linkedin
  • logo email
Logo Metamed
Proparco's $20 million investment will support one of the regional leaders in private medical imaging and will improve patients' access to affordable services in Egypt, Saudi Arabia and Jordan.

MetaMed, a company founded in 2009, currently operates 27 medical imaging and analysis centers in the Middle East. The transaction, in which Proparco is participating alongside other development finance institutions (FMO, DEG, EBRD) and led by private equity firm Mediterrania Capital Partners (MCP), will enable the acquisition of Metamed and its integration with CairoScan, another major player in the sector in which MCP invested in 2018, to form an important regional platform for imaging and medical biology laboratories.

This operation will support the opening of new medical imaging centres in the region, thus improving access to medical imaging services at an affordable price. Nearly 2 million patients in Egypt, Saudi Arabia and Jordan could benefit from this operation by 2024.

More than 1,600 direct jobs, including 600 held by women, are also expected to be created or maintained over the next 5 years.